Search results
Analyst Report: Amgen Inc.
Morningstar Research via Yahoo Finance· 18 hours agoAmgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla ...
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug
Investor's Business Daily· 6 months agoAmgen handily beat Wall Street's earnings forecasts Tuesday, but Amgen stock tumbled after the...
Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 1 year agoAmgen AMGN reported first-quarter 2023 earnings of $3.98 per share, which beat the Zacks Consensus...
Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoFor new and old investors, taking full advantage of the stock market and investing with confidence...
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
Zacks via Yahoo Finance· 2 years agoAmgen AMGN reported second-quarter 2022 earnings of $4.65 per share, which beat the Zacks Consensus...
Amgen 1st quarter profit falls as costs rise, sales up 2%
Reuters via Yahoo Finance· 1 year ago(Reuters) -Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2%...
Amgen (AMGN) Down 6.5% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 months agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value
GuruFocus.com via Yahoo Finance· 7 months agoAs of October 10, 2023, Amgen Inc (NASDAQ:AMGN) experienced a day's loss of -1.02%, with a 3-month...